These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9584851

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Properties of pyruvate kinase isozyme from rat ascites hepatoma 13 cells].
    Tachikawa A.
    Josai Shika Daigaku Kiyo; 1984; 13(1):1-17. PubMed ID: 6098325
    [No Abstract] [Full Text] [Related]

  • 24. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
    Kumar Y, Tapuria N, Kirmani N, Davidson BR.
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
    [Abstract] [Full Text] [Related]

  • 25. Different involvement for aldolase isoenzymes in kidney glucose metabolism: aldolase B but not aldolase A colocalizes and forms a complex with FBPase.
    Yañez AJ, Ludwig HC, Bertinat R, Spichiger C, Gatica R, Berlien G, Leon O, Brito M, Concha II, Slebe JC.
    J Cell Physiol; 2005 Mar; 202(3):743-53. PubMed ID: 15389646
    [Abstract] [Full Text] [Related]

  • 26. Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation.
    Spoden GA, Mazurek S, Morandell D, Bacher N, Ausserlechner MJ, Jansen-Dürr P, Eigenbrodt E, Zwerschke W.
    Int J Cancer; 2008 Jul 15; 123(2):312-321. PubMed ID: 18425820
    [Abstract] [Full Text] [Related]

  • 27. Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK).
    Oremek GM, Gerstmeier F, Sauer-Eppel H, Sapoutzis N, Wechsel HW.
    Anticancer Res; 2003 Jul 15; 23(2A):1127-30. PubMed ID: 12820359
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture.
    Weinhouse S.
    Cancer Res; 1972 Oct 15; 32(10):2007-16. PubMed ID: 4343003
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pyruvate kinase inhibited by L-cysteine as a marker of tumorigenic human urothelial cell lines.
    Gumińska M, Stachurska MB, Christensen B, Tromholt V, Kieler J, Radzikowski C, Duś D.
    Experientia; 1989 Jun 15; 45(6):571-4. PubMed ID: 2737264
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma.
    Kaura B, Bagga R, Patel FD.
    J Obstet Gynaecol Res; 2004 Jun 15; 30(3):193-6. PubMed ID: 15210041
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.
    Dombrauckas JD, Santarsiero BD, Mesecar AD.
    Biochemistry; 2005 Jul 12; 44(27):9417-29. PubMed ID: 15996096
    [Abstract] [Full Text] [Related]

  • 39. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.
    Mazurek S, Zwerschke W, Jansen-Dürr P, Eigenbrodt E.
    Biochem J; 2001 May 15; 356(Pt 1):247-56. PubMed ID: 11336658
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.